Zomepirac Sodium

CHEMBL3989403 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

349.7 g/mol

LogP

—

Phase

4

Zomepirac sodium is the sodium salt of zomepirac, a COX-inhibiting NSAID used for analgesic and anti-inflammatory purposes before market withdrawal due to anaphylactic hypersensitivity reactions. The sodium salt form was used in oral tablet formulations for pain management. Its withdrawal highlighted the importance of post-marketing surveillance for rare but serious hypersensitivity reactions to NSAIDs.

Moleküler Ağırlık

349,7400 g/mol

TPSA

64,10 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cc(CC(=O)[O-])n(C)c1C(=O)c1ccc(Cl)cc1.O.O.[Na+]

InChI

InChI=1S/C15H14ClNO3.Na.2H2O/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10;;;/h3-7H,8H2,1-2H3,(H,18,19);;2*1H2/q;+1;;/p-1

Molecular Formula

C15H17ClNNaO5

HBD / HBA

2 / 5

Döndürülebilir Bağlar

4

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Zomepirac sodium is the sodium salt of zomepirac, a COX-inhibiting NSAID used for analgesic and anti-inflammatory purposes before market withdrawal due to anaphylactic hypersensitivity reactions. The sodium salt form was used in oral tablet formulations for pain management. Its withdrawal highlighted the importance of post-marketing surveillance for rare but serious hypersensitivity reactions to NSAIDs.

Yes, Zomepirac Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989403. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23663418. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Zomepirac Sodium PillFYI'da

Yapı

Hızlı Veriler

Formül: C15H17ClNNaO5

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.